Practice
Specialties
Hygiene
Clinical
Business
Cases
Careers
Tariffs
Sign In
Endodontics
Oral & Maxillofacial Surgery
Orofacial Pain
Orthodontics
Pediatrics
Periodontics
Smile Design
Analgesics: Page 37
Jurors weigh jaw risk of osteoporosis drug Fosamax
By
Reuters Health
NEW YORK (Reuters), Sep 3 - Jurors heard sharply different closing arguments on Wednesday in a trial over whether or not Merck & Co.'s Fosamax drug treatment for osteoporosis caused a Florida woman's jaw damage.
September 2, 2009
Articaine wins in mandibular infiltration study
By
Laird Harrison
Will mandibular infiltration ever replace the inferior alveolar nerve block? Researchers have been picking away at this question for years. An article in this month's
Journal of the American Dental Association
brought them another step closer to the answer.
August 26, 2009
Milestone Scientific gets notice of allowance on patent
By
DrBicuspid.com staff writers
The U.S. Patent and Trademark Office has issued a notice of allowance to Milestone Scientific for its U.S. patent application directed to the use of a disposable handpiece for fluid administration.
August 23, 2009
Lawyer recommends reporting drug-induced xerostomia to FDA
By
DrBicuspid.com staff writers
Dentists should report cases of xerostomia caused by medications to the FDA, Edwin Zinman, D.D.S., J.D., told attendees at the World Congress of Minimally Invasive Dentistry annual meeting.
August 18, 2009
OraPharma offers dental students Arestin training
By
DrBicuspid.com staff writers
OraPharma recently renewed the Arestin Student Access Program and created a new Professional Affairs Team to provide field support and instructor training for the program.
August 12, 2009
Milestone Scientific Q2 revenues up 52%
By
DrBicuspid.com staff writers
Milestone Scientific reported an increase of 52% in net revenues for the second quarter of this year.
August 11, 2009
New osteoporosis drug may avoid osteonecrosis
By
DrBicuspid.com staff writers
Denosumab, an investigational new drug for osteoporosis, increased patients' bone density without causing osteonecrosis of the jaw in a new study.
August 11, 2009
Merck denies Fosamax caused woman's ONJ
By
DrBicuspid.com staff writers
Merck said it will "vigorously defend itself" in the first of what is expected to be several liability trials involving the company's osteoporosis drug Fosamax.
August 10, 2009
Computerized anesthetic system found equal to manual
By
DrBicuspid.com staff writers
The Wand computer-controlled local anesthetic system from Milestone Scientific caused no more or less pain than conventional injections in a recent study.
August 10, 2009
Glibenclamide can discolor teeth in children with neonatal diabetes
By
Reuters Health
NEW YORK (Reuters Health), Aug 10 - Glibenclamide (glyburide) use has been associated with tooth discoloration in at least five children treated for neonatal diabetes, according to a report in the August issue of
Diabetes Care
.
August 9, 2009
Merck faces bellwether Fosamax lawsuit
By
DrBicuspid.com staff writers
The first of some 900 lawsuits filed against Merck claiming that its osteoporosis drug Fosamax causes osteonecrosis of the jaw (ONJ) is set to go to trial this week in New York.
August 9, 2009
Lexi-Comp launches oral surgery online resource
By
DrBicuspid.com staff writers
Lexi-Comp has released Lexi-Comp Online for Oral Surgery, a customized Internet-based resource designed for oral surgery specialists.
August 5, 2009
Previous Page
Page 37 of 43
Next Page